National Institute for Health and Care Excellence

NHS England cuts treatments from Cancer Drugs Fund

After a second assessment of the Cancer Drugs Fund, NHS England has further reduced the list by 17 drugs for 23 different indications.…

Referral to regulator for inappropriate antibiotics prescribing may have to be considered

Inappropriate prescribing of antibiotics may have to be sanctioned in the future. …

NICE recommends tighter glucose control in updated diabetes guidelines

Updated national guidelines for adults with type 1 diabetes, for children and young people with types 1 and 2 diabetes and for patients with diabetic foot problems have been published by the National Institute for Health and Care Excellence.…

UK doctors could be reported for inappropriate antibiotic prescribing

Healthcare professionals should question their colleagues’ prescribing of antimicrobials when they don’t comply with local or national guidelines, according to Mark Baker, director of the clinical centre for practice at the National Institute for Health and Care Excellence.…

Appoint pharmacy champions to lead introduction of biosimilars, says NICE

NHS trusts should appoint pharmacy and clinical champions to lead on biosimilar medicines, according to the National Institute for Health and Care Excellence.…

Clinical Pharmacist’s monthly news round-up: the top 10 in the past month

What has been happening in the world of pharmacy? Here’s our pick of must-read news from the past month.…

Proposal to involve NICE in approval process for Cancer Drugs Fund

The evaluation of drugs currently funded under the Cancer Drugs Fund (CDF) could be passed over to National Institute for Health and Care Excellence (NICE) under proposals drawn up by NHS England.…

New home for prescribing framework

All healthcare professionals who prescribe must follow a common set of principles, and the pharmacy profession is an appropriate steward for a prescribing framework.…

NICE’s assessment process is stifling pharmaceutical innovation

The way new medicines are assessed should be reformed to provide patients with the best treatments and stimulate research and innovation in the UK.…

Labelling price of medicines won’t solve the real problem

Putting the price of a medicine on the packet may not improve medicines adherence and may have unintended consequences, writes Paul Gimson.…